Scientists probe key protein in colorectal Cancer's spread to liver
NCT ID NCT07497789
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at why colorectal cancer spreads to the liver. Researchers will collect tumor samples from 156 patients during surgery to study a protein called SMYD3. They believe SMYD3 helps cancer cells survive and grow in the liver by changing how cells use energy and handle stress. The goal is to find new ways to block this process and develop better treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRC (COLORECTAL CANCER) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a four-pronged attack shrink liver tumors enough for surgery?
- Can a Two-Pronged antibody boost chemo against Hard-to-Treat colorectal cancer?
- New drug cocktail aims to shrink Hard-to-Treat colorectal tumors
- Real-World data on colorectal cancer: what happens to patients over time?
- Engineered immune cells take on Hard-to-Treat colorectal cancer
- AI aims to improve colon polyp measurement for cancer prevention